Article
In vivo metabolic phenotyping of myocardial substrate metabolism in rodents: differential efficacy of metformin and rosiglitazone monotherapy.
Circulation. Cardiovascular imaging - 1 Sept 2009
Shoghi Kooresh I, Finck Brian N, Schechtman Kenneth B, Sharp Terry, Herrero Pilar, Gropler Robert J, Welch Michael J
Abstract excerpt
BACKGROUND: Cardiovascular disease is the leading cause of death among diabetic patients, with alteration in myocardial substrate metabolism being a likely contributor. We aimed to assess noninvasively the efficacy of metformin and rosiglitazone monotherapy in normalizing myocardial substrate metabolism in an animal model of type 2 diabetes mellitus. METHODS AND RESULTS: The study used 18 male ZDF rats (fa/fa)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
